ALKS News and Press, Alkermes plc

2024-07-23 13:36:18 ET More on Alkermes The Bottom Fishing Club: Alkermes Has Great Value And Safety Alkermes plc (ALKS) Q1 2024 Earnings Call Transcript Alkermes plc 2024 Q1 - Results - Earnings Call Presentation Alkermes Q1 2024 Earnings Preview See...

2024-07-22 10:45:03 ET Enbridge Inc (ENB) ENB is trading UP for the last 5 days, and it at trading at $36.59 with volume of 731,965 and a one day change of $0.05 (0.14%). Enbridge Inc has a 52-week low of 31.03 and a 52-week high of $38.36. The business's 50-day moving average price...

Alkermes to Report Second Quarter Financial Results on July 24, 2024 PR Newswire DUBLIN , July 17, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET ( 1:00 p.m. BST ) on Wednesday, ...

2024-07-17 10:47:28 ET Summary Monthly article series reports aggregate industry metrics in healthcare. Healthcare providers and life science tools are moderately overvalued, while pharmaceuticals and biotechnology have the worst value and quality scores. Fidelity MSCI Health ...

2024-06-29 16:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-06-19 17:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-06-16 10:23:34 ET Summary This monthly article series provides a dashboard with aggregate industry metrics in healthcare. The healthcare sector is moderately overvalued relative to 11-year averages, and healthcare providers are the least overvalued subsector. Focus on IHF...

Alkermes Presents Data From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 1 at SLEEP 2024 PR Newswire — Orexin 2 Receptor Agonist ALKS 2680 Demonstrated Clinically Meaningful and Statistically Significant Improvemen...

2024-05-29 01:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Alkermes to Present New Clinical Data for ALKS 2680 at SLEEP 2024 PR Newswire – Late-Breaking Abstracts Containing Data From the Full Narcolepsy Type 1 Cohort From the ALKS 2680 Phase 1b Study and Vibrance-1 Phase 2 Study Design Accepted for Poster Presentations &#x...